Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin + ezetimibe vs atorvastatin in Korean patients with type 2 diabetes mellitus and hypercholesterolemia
KCT0010493Phase 4Recruiting
- Sponsor
- Yuhan
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of atorvastatin, ezetimibe in type 2 diabetes mellitus (T2DM), hypercholesterolemia, sponsored by Yuhan. Started Aug 2025; status: recruiting.
02
Drugs
atorvastatinezetimibe
03
Conditions
type 2 diabetes mellitus (T2DM)hypercholesterolemia
Beyond the preview
Go deeper on KCT0010493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0010493.